Ivan Koychev
PhD MRCPsych
Senior Clinical Researcher
- Clinician Scientist Dementias Platform UK
- Consultant Neuropsychiatrist Oxford University Hospitals NHS Foundation Trust
I am a clinical academic psychiatrist (on the GMC Specialist Register for Old Age and General Adult Psychiatry) with a focus on the development of treatments for neuropsychiatric disorders. My research spans the key components of neuroscience clinical trial methodology: conduct of proof-of-concept (PoC) biomarker-based clinical trials in surrogate populations, testing of repurposed compounds, development of stratification and efficacy biomarkers and creation of infrastructure for large-scale stratified recruitment into neuroscience experimental medicine studies and clinical trials. Clinically, I focus on the assessment and management of patients with neuropsychiatric presentations in acute medical settings.
Key publications
-
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.
Journal article
Koychev I. et al, (2017), J Alzheimers Dis, 60, 283 - 293
-
Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.
Journal article
Koychev I. et al, (2020), J Alzheimers Dis
-
Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease.
Journal article
Koychev I. et al, (2019), BMJ Open, 9
-
Prediction of Alzheimer's disease biomarker status defined by the 'ATN framework' among cognitively healthy individuals: results from the EPAD longitudinal cohort study.
Journal article
Calvin CM. et al, (2020), Alzheimers Res Ther, 12
-
Real-world effectiveness, its predictors and onset of action of cholinesterase inhibitors and memantine in dementia: retrospective health record study.
Journal article
Vaci N. et al, (2020), Br J Psychiatry, 1 - 7
-
Dementias Platform UK Clinical Studies and Great Minds Register: protocol of a targeted brain health studies recontact database.
Journal article
Koychev I. et al, (2020), BMJ Open, 10
Recent publications
-
Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis
Journal article
KOYCHEV I. et al, (2021), Brain Communications
-
Secondary prevention of dementia: Combining risk factors and scalable screening technology
Journal article
KOYCHEV I. and Ojakäär T., (2021), Frontiers in Neurology
-
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.
Journal article
Sen A. et al, (2021), Trials, 22
-
An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): A Double-Blind, Placebo Controlled, Randomised Cross Over Proof of Concept Study
Journal article
Sen A. et al, (2021)
-
Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives.
Journal article
Rogers JP. et al, (2021), J Neurol Neurosurg Psychiatry